ATE105570T1 - Modifizierte menschliche anti-rh(d)-antikoerper. - Google Patents

Modifizierte menschliche anti-rh(d)-antikoerper.

Info

Publication number
ATE105570T1
ATE105570T1 AT9090912594T AT90912594T ATE105570T1 AT E105570 T1 ATE105570 T1 AT E105570T1 AT 9090912594 T AT9090912594 T AT 9090912594T AT 90912594 T AT90912594 T AT 90912594T AT E105570 T1 ATE105570 T1 AT E105570T1
Authority
AT
Austria
Prior art keywords
antibodies
human anti
modified human
reagent
preparation
Prior art date
Application number
AT9090912594T
Other languages
English (en)
Inventor
Marion Lesley Scott
Alan Robert Guest
David John Anstee
Original Assignee
Nat Blood Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Blood Authority filed Critical Nat Blood Authority
Application granted granted Critical
Publication of ATE105570T1 publication Critical patent/ATE105570T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT9090912594T 1989-09-01 1990-08-31 Modifizierte menschliche anti-rh(d)-antikoerper. ATE105570T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898919761A GB8919761D0 (en) 1989-09-01 1989-09-01 Chemical compounds
PCT/EP1990/001463 WO1991003492A1 (en) 1989-09-01 1990-08-31 MODIFIED HUMAN ANTI-Rh(D) ANTIBODIES

Publications (1)

Publication Number Publication Date
ATE105570T1 true ATE105570T1 (de) 1994-05-15

Family

ID=10662373

Family Applications (1)

Application Number Title Priority Date Filing Date
AT9090912594T ATE105570T1 (de) 1989-09-01 1990-08-31 Modifizierte menschliche anti-rh(d)-antikoerper.

Country Status (9)

Country Link
EP (1) EP0489771B1 (de)
AT (1) ATE105570T1 (de)
AU (1) AU645263B2 (de)
CA (1) CA2065278A1 (de)
DE (1) DE69008859T2 (de)
DK (1) DK0489771T3 (de)
ES (1) ES2052267T3 (de)
GB (1) GB8919761D0 (de)
WO (1) WO1991003492A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005263334C1 (en) 2004-07-20 2011-01-20 Symphogen A/S A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
KR20070038556A (ko) 2004-07-20 2007-04-10 심포젠 에이/에스 항-ｒｈｅｓｕｓ ｄ 재조합 폴리클로날 항체 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296090A (en) * 1979-07-13 1981-10-20 Ortho Diagnostics, Inc. Anti-D test and reagent
NZ194251A (en) * 1979-07-13 1983-06-17 Ortho Diagnostics Rapid determination of antigens on red blood cells and reagent therefor
NZ194363A (en) * 1979-12-26 1982-12-21 Gamma Biologicals Inc Producing anti-serum
AU622417B2 (en) * 1987-09-18 1992-04-09 National Blood Authority Human anti-rh(d) monoclonal antibodies
GB8722019D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722020D0 (en) * 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
AU623345B2 (en) * 1987-09-18 1992-05-14 National Blood Authority Human anti-rh(d) monoclonal antibodies

Also Published As

Publication number Publication date
CA2065278A1 (en) 1991-03-02
EP0489771A1 (de) 1992-06-17
DE69008859T2 (de) 1994-09-08
DE69008859D1 (de) 1994-06-16
GB8919761D0 (en) 1989-10-18
WO1991003492A1 (en) 1991-03-21
AU6185690A (en) 1991-04-08
DK0489771T3 (da) 1994-06-13
AU645263B2 (en) 1994-01-13
EP0489771B1 (de) 1994-05-11
ES2052267T3 (es) 1994-07-01

Similar Documents

Publication Publication Date Title
GB2364304A (en) Novel tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
EE200000318A (et) Uudsed ühendid
PT83873B (pt) Processo de preparacao de medicamentos contendo hexadecilfosfocolina
IE842979L (en) Desulfatohirudins
SE9704546D0 (sv) Novel compounds
ID21682A (id) Turunan-turunan pirolo [3,4-d] pirimidinon dan penggunaannya sebagai obat-obatan
ZA909903B (en) New compounds
NO178768C (no) 11-aryl-4-östrener og antikonsepsjonsmidler inneholdende disse
AU653937B2 (en) Water-soluble polypeptides having high affinity for interferons alpha and beta
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
SE9702305D0 (sv) New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
DK157016C (da) 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconat, laegemidler indeholdende dette samt fremstilling af disse laegemidler
AU7775398A (en) Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
ATE105570T1 (de) Modifizierte menschliche anti-rh(d)-antikoerper.
ATE85328T1 (de) Substituierte toluidine, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer.
HUT49876A (en) Process for producing 6-oxopyridazine derivatives and pharmaceutical compositions comprising same
DE69804766D1 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
IT8721436A0 (it) "derivati di 2,3,4,5,6,7 esaidro 2,7 metano 1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti.
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.
DK89289A (da) Anvendelse af 1,4-dihydropyridin-derivater til fremstilling af laegemiddel til afvaenning af alkoholister
MY113432A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and medicaments containing them
DE3761561D1 (de) N,n-bis-(4-fluorophenyl)carbamoylacetohydroxamsaeure und diese enthaltende pharmazeutische zusammensetzungen.
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
ATE144986T1 (de) Aminoacylderivate von gem- diphosphonsauren,verfahren zu deren herstellung und pharmazeutische zubereitungen,die sie enthalten
IL87198A (en) Leukotriene antagonists,a process for the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee